It has been shown that taVNS may inhibit post-stoke inflammation response in the white matter of cerebral ischemia model rats through TLR4/NF-κB and MAPK/NF-κB signaling pathways (Long et al., 2022; Xu et al., 2023). This evidence concerns the gene NFKB1 and brain ischemia.